Efficacy of topical brinzolamide in children with retinal dystrophies

References

• Iida T, Yannuzzi LA, Spaide RF, Borodoker N, Carvalho CA, Negrao S. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina. 2003;23(1):1–7. quiz 137-8.
   PubMed Web of Science ®Google Scholar
• Kinsey VE, Reddy DV. Turnover of total carbon dioxide in the aqueous humors and the effect thereon of acetazolamide. AMA Arch Ophthalmol. 1959;62(1):78–83.
   PubMedGoogle Scholar
• Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol. 1989;107(10):1445–52. doi:10.1001/archopht.1989.01070020519031.
   PubMedGoogle Scholar
• Zhang L, Reyes R, Lee W, Chen CL, Chan L, Sujirakul T, Chang S, Tsang SH. Rapid resolution of retinoschisis with acetazolamide. Doc Ophthalmol. 2015;131(1):63–70. doi:10.1007/s10633-015-9496-8.
   PubMed Web of Science ®Google Scholar
• Lusthaus J, Goldberg I. Current management of glaucoma. Med J Aust. 2019;210(4):180–87. doi:10.5694/mja2.50020.
   PubMed Web of Science ®Google Scholar
• Whitson JT, Henry C, Hughes B, Lee DA, Terry S, Fechtner RD. Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension. J Glaucoma. 2004;13(2):168–73.
   PubMed Web of Science ®Google Scholar
• Apushkin MA, Fishman GA. Use of dorzolamide for patients with X-linked retinoschisis. Retina. 2006;26(7):741–45. doi:10.1097/01.iae.0000237081.80600.51.
   PubMed Web of Science ®Google Scholar
• Collison FT, Genead MA, Fishman GA, Stone EM. Resolution of mid-peripheral schisis in x-linked retinoschisis with the use of dorzolamide. Ophthalmic Genet. 2014;35(2):125–27. doi:10.3109/13816810.2013.779383.
   PubMed Web of Science ®Google Scholar
• Michaud JE, Friren B. Group IBAS, Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001;132(2):235–43. doi:10.1016/s0002-9394(01)00974-6.
   PubMed Web of Science ®Google Scholar
• DeSantis L. Preclinical overview of brinzolamide. Surv Ophthalmol. 2000;44(Suppl 2):S119–29.
   PubMed Web of Science ®Google Scholar
• Yang FP, Willyasti K, Leo SW. Topical brinzolamide for foveal schisis in juvenile retinoschisis. J Aapos. 2013;17(2):225–27. doi:10.1016/j.jaapos.2012.11.016.
   PubMed Web of Science ®Google Scholar
• Fishman GA, Apushkin MA. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa. Br J Ophthalmol. 2007;91(6):743–45. doi:10.1136/bjo.2006.107466.
   PubMed Web of Science ®Google Scholar
• Genead MA, Fishman GA, Walia S. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Arch Ophthalmol. 2010;128(2):190–97. doi:10.1001/archophthalmol.2009.398.
   PubMedGoogle Scholar
• Liew G, Moore AT, Webster AR, Michaelides M. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2015;56(3):1531–36. doi:10.1167/iovs.14-15995.
   PubMed Web of Science ®Google Scholar
• Pennesi ME, Birch DG, Jayasundera KT, Parker M, Tan O, Gurses-Ozden R, Reichley C, Beasley KN, Yang P, Weleber RG, et al. Prospective evaluation of patients with X-linked retinoschisis during 18 months. Invest Ophthalmol Vis Sci. 2018;59(15):5941–56. doi:10.1167/iovs.18-24565.
   PubMed Web of Science ®Google Scholar
• Mincione F, Scozzafava A, Supuran CT. The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des. 2008;14(7):649–54. doi:10.2174/138161208783877866.
   PubMed Web of Science ®Google Scholar
• Iester M, Altieri M, Michelson G, Vittone P, Traverso CE, Calabria G. Retinal peripapillary blood flow before and after topical brinzolamide. Ophthalmologica. 2004;218(6):390–96. doi:10.1159/000080942.
   PubMed Web of Science ®Google Scholar
• Iester M. Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension. Clin Ophthalmol. 2008;2(3):517–23. doi:10.2147/opth.s3182.
   PubMedGoogle Scholar
• Kaup M, Plange N, Niegel M, Remky A, Arend O. Effects of brinzolamide on ocular haemodynamics in healthy volunteers. Br J Ophthalmol. 2004;88(2):257–62. doi:10.1136/bjo.2003.021485.
   PubMed Web of Science ®Google Scholar
• Siesky B, Harris A, Sines D, Rechtman E, Malinovsky VE, McCranor L, Yung C-W, Zalish M. A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma. J Ocul Pharmacol Ther. 2006;22(5):353–61. doi:10.1089/jop.2006.22.353.
   PubMed Web of Science ®Google Scholar
• Coussa RG, Kapusta MA. Treatment of cystic cavities in X-linked juvenile retinoschisis: the first sequential cross-over treatment regimen with dorzolamide. Am J Ophthalmol Case Rep. 2017;8:1–3. doi:10.1016/j.ajoc.2017.07.008.
   PubMedGoogle Scholar
• Thurtell MJ, Leigh RJ. Treatment of nystagmus. Curr Treat Options Neurol. 2012;14(1):60–72. doi:10.1007/s11940-011-0154-5.
   PubMed Web of Science ®Google Scholar
• Kahook MY, Noecker RJ, Ishikawa H, Wollstein G, Kagemann L, Wojtkowski M, Duker JS, Srinivasan VJ, Fujimoto JG, Schuman JS. Peripapillary schisis in glaucoma patients with narrow angles and increased intraocular pressure. Am J Ophthalmol. 2007;143(4):697–99. doi:10.1016/j.ajo.2006.10.054.
   PubMed Web of Science ®Google Scholar
• Selvan H, Sharma A, Birla S, Gupta S, Somarajan BI, Gupta V. Molecular characterization of a rare phenotype of X-linked retinoschisis with angle-closure glaucoma. Indian J Ophthalmol. 2019;67(7):1226–29. doi:10.4103/ijo.IJO_1407_18.
   PubMed Web of Science ®Google Scholar
• Low S, Mohamed R, Ting M, Webster AR, Garway-Heath DF. The treatment of refractory angle-closure glaucoma in a patient with X-linked juvenile retinoschisis. Ophthalmic Genet. 2018;39(5):625–27. doi:10.1080/13816810.2018.1490961.
   PubMed Web of Science ®Google Scholar
• Ritch R, Chang BM, Liebmann JM. Angle closure in younger patients. Ophthalmology. 2003;110(10):1880–89. doi:10.1016/S0161-6420(03)00563-3.
   PubMed Web of Science ®Google Scholar